What is ORGO (ORGO) stock price today?

ORGO (ORGO) is currently trading at $1.67, up 2.45% today.

What is ORGO P/E ratio?

ORGO's P/E ratio is -2.04. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ORGO return on equity (ROE)?

ORGO's return on equity (ROE) is -24.23%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is ORGO's market cap?

ORGO has a market capitalization of $214.89M.

NASDAQ · Drug Manufacturers - Specialty & Generic

ORGO (ORGO) Stock

$1.67 +2.45% NASDAQ: ORGO Healthcare

Valuation

Metric	Value
Price	$1.67
Market Cap	$214.89M
P/E Ratio	-2.04
P/B Ratio	0.75
P/S Ratio	0.47
EPS (TTM)	$0.15
52-Week High	$7.08
52-Week Low	$1.54
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-24.23%
ROA	-22.20%
ROCE	-8.34%
Gross Margin	9.95%
Operating Margin	9.95%
Net Margin	-19.76%
Debt/Equity	0.23
Current Ratio	3.62

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$467.0M	$451.0M	$433.0M	$482.0M	$563.0M
Operating Profit	$72.0M	$22.0M	$13.0M	$-1.0M	$56.0M
Net Profit	$94.0M	$16.0M	$5.0M	$1.0M	$37.0M
EPS	$0.70	$0.12	$0.04	$-0.01	$0.15
Op Margin	15.4%	5.0%	2.9%	-0.3%	9.9%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$443.0M	$449.0M	$460.0M	$498.0M	$599.0M
Total Liabilities	$202.0M	$184.0M	$181.0M	$113.0M	$165.0M
Cash	$114.0M	$102.0M	$104.0M	$136.0M	$94.0M
Borrowings	$132.0M	$124.0M	$119.0M	$43.0M	$133.0M

Latest News

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 GlobeNewswire · Jul 9, 2026 Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis GlobeNewswire · Jul 6, 2026 Is Organogenesis Holdings Inc. (ORGO) Losing Momentum? BTIG Pulls Buy Rating After Q1 Update Insider Monkey · May 20, 2026 Spotlight On Penny Stocks To Consider In May 2026 Simply Wall St. · May 14, 2026 Undervalued Small Caps With Insider Buying To Watch In May 2026 Simply Wall St. · May 14, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$62.0M	$25.0M	$31.0M	$14.0M	$-10.0M
Investing Cash Flow	$-62.0M	$-68.0M	$-49.0M	$-20.0M	$-28.0M
Financing Cash Flow	$-1.0M	$1.0M	$0	$-24.0M	$-16.0M
Net Cash Flow	$30.0M	$-11.0M	$1.0M	$32.0M	$-42.0M
Free Cash Flow	$31.0M	$-9.0M	$7.0M	$4.0M	$-24.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-49.86
FCF Yield	9.70%
Quick Ratio	3.00
Interest Coverage	0.00
Return 1Y	-51.20%
Return 3Y	-41.45%
Return 5Y	-85.16%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ANGO	$15.62	-1.51%	-14.36	$645.61M	0.00%
BCYCBicycle Therapeutics plc	$4.22	+0.24%	-1.34	$292.84M	0.00%
CMPX	$2.43	+5.19%	-4.71	$437.61M	0.00%
EBS	$6.46	+3.86%	8.67	$333.31M	0.00%
EOLS	$9.06	-0.22%	-16.95	$596.64M	0.00%

About ORGO

ORGO is led by CEO Gary S. Gillheeney, employs 869 people, headquartered in US, publicly traded since 2017.

ORGO stock trades at $1.67 with a market capitalization of $214.89M. The stock is valued at a price-to-earnings (P/E) ratio of -2.04, price-to-book of 0.75, price-to-sales of 0.47. Over the past 52 weeks the stock has ranged between $1.54 and $7.08, and currently trades 76.4% below its 52-week high.

On profitability, ORGO generates a return on equity (ROE) of -24.23%, return on capital employed of -8.34%, an operating margin of 9.95%, a net profit margin of -19.76%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides